ArticleBMC health services research2023

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis.

Saharat Aungsumart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.